Port-Site Metastasis in Gynecological Malignancies.
CO2 insufflation
Cervical cancer
Gynecologic malignancy
Port-site metastasis
Journal
JSLS : Journal of the Society of Laparoendoscopic Surgeons
ISSN: 1938-3797
Titre abrégé: JSLS
Pays: United States
ID NLM: 100884618
Informations de publication
Date de publication:
Historique:
entrez:
21
4
2021
pubmed:
22
4
2021
medline:
6
7
2021
Statut:
ppublish
Résumé
Minimally invasive oncologic surgery has become the standard of care in many gynecologic cancers. While laparoscopic surgery provides many benefits to patients, such as faster recovery, there are unique challenges associated with minimally invasive techniques. Port-site metastasis is a rare complication after laparoscopic oncologic surgery in management of gynecologic malignancies. We present the case of a 44-year-old female with isolated port-site recurrence following laparoscopic radical hysterectomy with node-negative, clinical stage IB1 cervical adenocarcinoma. In addition, we provide an updated review of the literature on management and oncologic outcomes of port-site metastasis. Port-site metastasis prevention necessitates a better understanding of underlying risk factors and pathophysiology in order to optimize outcomes. Future studies are needed on risk-reducing strategies and standardization of management for port-site metastasis.
Sections du résumé
BACKGROUND
BACKGROUND
Minimally invasive oncologic surgery has become the standard of care in many gynecologic cancers. While laparoscopic surgery provides many benefits to patients, such as faster recovery, there are unique challenges associated with minimally invasive techniques. Port-site metastasis is a rare complication after laparoscopic oncologic surgery in management of gynecologic malignancies.
METHODS
METHODS
We present the case of a 44-year-old female with isolated port-site recurrence following laparoscopic radical hysterectomy with node-negative, clinical stage IB1 cervical adenocarcinoma. In addition, we provide an updated review of the literature on management and oncologic outcomes of port-site metastasis.
CONCLUSION
CONCLUSIONS
Port-site metastasis prevention necessitates a better understanding of underlying risk factors and pathophysiology in order to optimize outcomes. Future studies are needed on risk-reducing strategies and standardization of management for port-site metastasis.
Identifiants
pubmed: 33879998
doi: 10.4293/JSLS.2020.00081
pii: JSLS.2020.00081
pmc: PMC8035826
pii:
doi:
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Informations de copyright
© 2021 by SLS, Society of Laparoscopic & Robotic Surgeons.
Déclaration de conflit d'intérêts
Conflict of Interest: none.
Références
Am J Obstet Gynecol. 1984 Oct 1;150(3):297-9
pubmed: 6486195
Gynecol Oncol. 1999 May;73(2):177-83
pubmed: 10329031
J Endourol. 2003 Nov;17(9):771-5
pubmed: 14642041
Gynecol Oncol. 1999 Jan;72(1):38-44
pubmed: 9889027
Int J Gynecol Cancer. 2011 Jul;21(5):936-40
pubmed: 21633306
Int J Gynecol Cancer. 2015 Jun;25(5):869-74
pubmed: 25790043
Am J Obstet Gynecol. 2003 Jul;189(1):16-21
pubmed: 12861132
Gynecol Oncol. 2003 Oct;91(1):179-89
pubmed: 14529679
Gynecol Oncol. 1996 Feb;60(2):233-7
pubmed: 8631544
Am J Obstet Gynecol. 1999 Sep;181(3):536-41
pubmed: 10486460
Gynecol Oncol. 1987 Nov;28(3):255-61
pubmed: 3678976
Surg Endosc. 2001 Feb;15(2):121-5
pubmed: 11285951
Surg Endosc. 2002 Aug;16(8):1170-4
pubmed: 12189478
Am J Obstet Gynecol. 1992 Jan;166(1 Pt 1):50-3
pubmed: 1733218
J Minim Invasive Gynecol. 2012 Jul-Aug;19(4):531-7
pubmed: 22748961
BJOG. 2001 Aug;108(8):809-12
pubmed: 11510704
Clin Obstet Gynecol. 2017 Jun;60(2):330-348
pubmed: 28406810
Int J Med Robot. 2010 Jun;6(2):132-5
pubmed: 20049750
Gynecol Oncol. 1999 Jul;74(1):130-3
pubmed: 10385565
Gynecol Oncol. 2005 Apr;97(1):292-5
pubmed: 15790481
J Pediatr Surg. 1998 Mar;33(3):457-61
pubmed: 9537557
J Clin Oncol. 2000 Apr;18(8):1606-13
pubmed: 10764420
Gynecol Oncol. 2008 Dec;111(3):431-7
pubmed: 18929404
Gynecol Oncol. 1991 Apr;41(1):46-51
pubmed: 2026359
Tumour Biol. 2014 Aug;35(8):7351-9
pubmed: 24744141
Int J Gynecol Cancer. 2004 Nov-Dec;14(6):1070-7
pubmed: 15571612
Taiwan J Obstet Gynecol. 2013 Dec;52(4):558-63
pubmed: 24411043
Surg Endosc. 1997 Sep;11(9):902-6
pubmed: 9294269
J Minim Invasive Gynecol. 2017 May - Jun;24(4):592-598
pubmed: 28126400
Gynecol Oncol. 1999 Feb;72(2):220-31
pubmed: 10021305
J Urol. 2004 Mar;171(3):1234-5
pubmed: 14767311
Gynecol Oncol. 2010 Aug 1;118(2):145-50
pubmed: 20451983
Obstet Gynecol. 2004 Mar;103(3):480-7
pubmed: 14990410
Obstet Gynecol. 1990 Oct;76(4):623-6
pubmed: 2216191
JSLS. 2004 Apr-Jun;8(2):133-9
pubmed: 15119657
Gynecol Oncol Rep. 2017 Mar 06;20:54-57
pubmed: 28331901